Form 4 for RMD ResMed|
Accepted 2025-11-13 00:00:00 ET · period of report 2025-11-11 · accession 0000943819-25-000115 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-13 | 2025-11-11 | RMD | De Witte Jan | Dir | F - Tax | $250.10 | -76.45 | 5,242 | -1% | -$19.1K | |
| 2025-11-13 | 2025-11-11 | RMD | De Witte Jan | Dir | S - Sale | $250.25 | -487 | 5,319 | -8% | -$121.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ReMed Common Stock | 2025-11-11 | F | D | 76.45 | $250.10 | 5,242 | D | — | — | |
| 2 | Common | ReMed Common Stock | 2025-11-11 | S | D | 487 | $250.25 | 5,319 | D | — | — |